Drug intelligence / Profile preview

umbilical cord tissue-derived mesenchymal stem cells (Xijing Hospital)

Development stage: Unknown
Lead developer: Xijing Hospital
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

This investigational cell therapy consists of allogeneic umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) developed by The First Affiliated Hospital of Air Force Medical University (also known as Xijing Hospital). It is currently being evaluated for the treatment of stage 3 or 4 chronic kidney disease (CKD) resulting from diabetic kidney disease or hypertensive nephropathy. The therapy utilizes the immunomodulatory, anti-inflammatory, and regenerative properties of mesenchymal stem cells to potentially slow disease progression and improve renal function, primarily assessed by changes in the estimated glomerular filtration rate (eGFR). The cells are administered via a single intravenous injection at a dose of 1.0×10^6 cells/kg.

Other names: allogeneic umbilical cord tissue-derived mesenchymal stem cells

Beyond the preview

Go deeper on umbilical cord tissue-derived mesenchymal stem cells (Xijing Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord tissue-derived mesenchymal stem cells (Xijing Hospital).

Explore the full profile